Overview
A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Access at 1 and 3 months. Subject participation will last up to 8 months (minimum 17 weeks pregnant through 3 months postpartum).
Eligibility
Inclusion Criteria:
- 17-32 weeks pregnant
- enrolled for prenatal care in one of the five identified practices
- English speaking
- able to use an app (audio/visual/dexterity)
- have one or more of the following PPD risk factors: Medicaid eligible; anxiety (GAD-7 > 10) during pregnancy; mild to moderate depressive symptoms (PHQ-9 = 10-19); self-reported history of depression treatment; gestational diabetes; and/or young age (18-21 years).
Exclusion Criteria:
- patients with acute mental health needs
- cannot communicate in English
- demonstrate significant cognitive impairment
- are planning to place the child for adoption
- PHQ-9 depression score > 19
- younger than age 18